27 institutions reported holding $19.9M of BioShares Biotechnology Clinical Trials Fund (BBC) in SEC 13F filings for 2026-06-30. Largest institutional holders: Kera Capital Partners, Inc. ($5.3M), WEALTH ENHANCEMENT ADVISORY SERVICES, LLC ($3.6M), Militia Capital Management LLC ($2.4M), CITADEL ADVISORS LLC ($2.3M), SUSQUEHANNA INTERNATIONAL GROUP, LLP ($2.1M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30